VOYA Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.45M | Sell |
|
|||||
|
2025
Q2 | $1.41M | Sell |
|
|||||
|
2025
Q1 | $12M | Sell |
|
|||||
|
2024
Q4 | $19.9M | Buy |
|
|||||
|
2024
Q3 | $19.9M | Buy |
|
|||||
|
2024
Q2 | $10.6M | Buy |
|
|||||
|
2024
Q1 | $2.31M | Sell |
|
|||||
|
2023
Q4 | $1.91M | Buy |
|
|||||
|
2023
Q3 | $1.57M | Buy |
|
|||||
|
2023
Q2 | $388K | Buy |
|
|||||
|
2023
Q1 | $331K | Hold |
|
|||||
|
2022
Q4 | $377K | Hold |
|
|||||
|
2022
Q3 | $405K | Buy |
|
|||||
|
2022
Q2 | $370K | Buy |
|
|||||
|
2022
Q1 | $384K | Buy |
|
|||||
|
2021
Q4 | $437K | Buy |
|
|||||
|
2021
Q3 | $297K | Hold |
|
|||||
|
2021
Q2 | $266K | Buy |
|
|||||
|
2021
Q1 | $203K | Buy |
|
|||||
|
2020
Q4 | $177K | Buy |
|